NeopharmCO.,LTD. Logo

NeopharmCO.,LTD.

Develops ceramide-based dermatological solutions for sensitive and baby skin.

092730 | KO

Overview

Corporate Details

ISIN(s):
KR7092730001
LEI:
Country:
South Korea
Address:
대전 유성구 탑립동 928번지, 대전
Sector:
Manufacturing
Industry:
Manufacture of other chemical products

Description

Neopharm Co., Ltd. is a company specializing in the development, manufacture, and sale of cosmetic and pharmaceutical products grounded in dermatological science and biotechnology. A leader in the sensitive skincare market, its portfolio is known for advanced solutions that promote skin homeostasis. The company's flagship brand, Atopalm, leverages proprietary ceramide-based technologies. Neopharm also offers baby care and other personal products. Founded with a strong focus on R&D, the company was incorporated into IT'S HANBUL in 2016.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.0 KB
2025-05-28 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.6 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-09 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 27.9 KB
2025-03-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.1 KB
2025-03-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 91.8 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-17 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 558.6 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 1.0 MB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all NeopharmCO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NeopharmCO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NeopharmCO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Outin Futures Co., Ltd. Logo
A global ODM providing one-stop cosmetic solutions for beauty brands, from concept to manufacturing.
South Korea
227610
Investing in sustainable manufacturers of industrial cleaning compounds and chemicals.
Bulgaria
HPLD
Papoutsanis S.A. Logo
European manufacturer of soap & cosmetics for own brands, hotels, and private label clients.
Greece
PAP
Park Ha Biological Technology Co., Ltd. Logo
Develops and sells private-label skincare for women through its network of stores and franchises.
United States of America
PHH
Develops and sells science-backed prestige cosmetics & skincare via personalized counseling.
Japan
4927
Premier Anti-Aging Co.,Ltd. Logo
Develops and sells anti-aging cosmetics and health foods for skin, hair, and inner care.
Japan
4934
PROCTER & GAMBLE Co Logo
Provides branded consumer goods globally in beauty, grooming, health, fabric, and family care.
United States of America
PG
Puig Brands SA Logo
Manages a global portfolio of premium fragrance, makeup, skincare, and fashion brands.
Spain
PUIG
PZ Cussons PLC Logo
Manufactures and distributes personal, beauty, and home care products globally.
United Kingdom
PZC

Talk to a Data Expert

Have a question? We'll get back to you promptly.